description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
ACTCGTCTTCCTGTGGCACTGAAGGCACCTTCCACCTCCCAGTGGACACCGGGACCGAGAACCGAACTTACCAAGCATCCTCTGCGGCTTTCAGATATACTGCGGGGACACCATACAAGGTCCCACCGACCCAGAGTAACACTGCTCCACCCCCCTACTCCCCATCACCCAACCCCTATCAGACGGCCATGTATCCAATCAGAAGTGCCTACCCCCAGCAGAATCTGTATGCCCAGGGAGCCTACTACACACAGCCGGTGTATGCTGCCCAGCCTCATGTCATCCACCATACCACGGTCGTCCAGCCCAACAGCATTCCCTCTGCTATCTACCCAGCACCTGTTGCCGCCCCGAGGACCAACGGTGTGGCCATGGGCATGGTGGCAGGCACCACCATGGCAATGTCAGCAGGTACCCTGCTGACTACACCCC
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Shuai Zhao et al.
Oncology reports, 43(6), 2017-2027 (2020-04-24)
Tamoxifen is widely used as a highly effective drug for treating estrogen‑receptor (ER) alpha‑positive breast cancer. However, tamoxifen resistance developed during cancer treatment remains a significant challenge. Tongue cancer resistance‑related protein1 (TCRP1), which is recognized as a novel drug target
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持